-
公开(公告)号:US20060073209A1
公开(公告)日:2006-04-06
申请号:US10958864
申请日:2004-10-05
申请人: Hsing-Wen Sung , Hsiang-Fa Liang , Ting-Fan Yang , Chin-Tsung Huang , Hosheng Tu
发明人: Hsing-Wen Sung , Hsiang-Fa Liang , Ting-Fan Yang , Chin-Tsung Huang , Hosheng Tu
IPC分类号: A61K31/704 , A61K31/7008 , A61K33/24 , A61K9/50
CPC分类号: A61K9/5153 , A61K31/7008 , A61K31/704 , A61K33/24 , A61K45/06 , A61K2300/00
摘要: The invention discloses the nanoparticles composed of γ-PGA-PLA block copolymers conjugated with galactosamine as a potential drug delivery system for treating liver cancers.
摘要翻译: 本发明公开了由与半乳糖结合的γ-PGA-PLA嵌段共聚物作为用于治疗肝癌的潜在药物递送系统的纳米颗粒。
-
公开(公告)号:US07348026B2
公开(公告)日:2008-03-25
申请号:US10958864
申请日:2004-10-05
申请人: Hsing-Wen Sung , Hsiang-Fa Liang , Ting-Fan Yang , Chin-Tsung Huang , Hosheng Tu
发明人: Hsing-Wen Sung , Hsiang-Fa Liang , Ting-Fan Yang , Chin-Tsung Huang , Hosheng Tu
CPC分类号: A61K9/5153 , A61K31/7008 , A61K31/704 , A61K33/24 , A61K45/06 , A61K2300/00
摘要: The invention discloses the nanoparticles composed of γ-PGA-PLA block copolymers conjugated with galactosamine as a potential drug delivery system for treating liver cancers.
摘要翻译: 本发明公开了由与半乳糖结合的γ-PGA-PLA嵌段共聚物作为用于治疗肝癌的潜在药物递送系统的纳米颗粒。
-
公开(公告)号:US20060034885A1
公开(公告)日:2006-02-16
申请号:US10929047
申请日:2004-08-27
申请人: Hsing-Wen Sung , Hsiang-Fa Liang , Chin-Tsung Huang , Hosheng Tu
发明人: Hsing-Wen Sung , Hsiang-Fa Liang , Chin-Tsung Huang , Hosheng Tu
IPC分类号: A61F13/00
CPC分类号: A61L31/10 , A61F2/92 , A61F2210/0004 , A61F2230/0054 , A61F2230/0091 , A61F2250/0067 , A61L31/148 , A61L31/16 , A61L2300/602 , A61L2300/61
摘要: The present invention relates to a drug-loaded biodegradable stent and methods for treating vulnerable plaques of a patient comprising a plurality of layers or zones, each layer or zone comprising its own specific biodegradation rate and its specific drug loading characteristics. In one embodiment, the layers and zones are configured and arranged, in combination, radially, circumferentially and longitudinally.
摘要翻译: 本发明涉及装载药物的可生物降解支架以及用于治疗包括多层或多个区域的患者脆弱斑块的方法,每个层或区域包含其自身特定的生物降解速率及其特定的药物负载特性。 在一个实施例中,层和区域被组合和组合地径向地,周向地和纵向地布置。
-
-